Skip to main content

Year: 2021

CSX Chief Executive Officer to Address Baird Global Industrial Conference

JACKSONVILLE, Fla., Nov. 04, 2021 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer James M. Foote will address the Baird 51st Annual Global Industrial Conference virtually on Thursday, November 11 at 10:50 am Eastern time. This address will be broadcast live via webcast at http://investors.csx.com. A replay will be available following the conclusion of this event. This announcement, as well as additional financial information, is available on the company’s website at http://investors.csx.com. About CSX and its Disclosures CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural, and consumer products....

Continue reading

IBC 2021 Sees Vislink and Mobile Viewpoint Demonstrate Leadership in Video Transport, 5G and AI-Assisted Remote Production

Hackettstown, NJ, Nov. 04, 2021 (GLOBE NEWSWIRE) — Vislink and Mobile Viewpoint will be exhibiting in person at IBC 2021, which will take place this year December 3-6 in RAI Amsterdam, the Netherlands. Their onsite teams will be in two locations on the show floor: Hall 1, stand #A63 and Hall 5, stand #H49. Show attendees can view the IBC floorplan and map the Vislink booth at this link. “IBC is particularly exciting for Vislink this year, as it’s the first time we’re exhibiting our new integrated product range, following the acquisition of Mobile Viewpoint earlier this year,” said Mickey Miller, CEO of Vislink. “This acquisition means that Vislink can now ensure our customers can acquire and deliver video however they need to, over any public or private network. IBC will see us making our Connected Edge video transport concept...

Continue reading

TScan Therapeutics Announces Upcoming Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition

WALTHAM, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that two abstracts related to its lead liquid tumor candidates TSC-100 and TSC-101 have been accepted for poster presentations at the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition, being held from December 11-14, 2021. Abstracts are available on the ASH website at www.hematology.org. TSC-100 and TSC-101 are TCR-T cell products directed against the minor histocompatibility antigens HA-1 and HA-2, respectively, which are found only on blood cells. TScan is developing these products to prevent relapse following hematopoietic cell transplant...

Continue reading

AppSwarm Announces Collaboration Agreement with KYN Capital Group for Application Development

Tulsa, OK, Nov. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AppSwarm, Corp. (OTC: SWRM), a software development company and aggregator of mobile applications, announces a memorandum of understanding (MOU) with KYN Capital Group (OTC: KYNC) to explore the collaboration and marketing of their blockchain and Pay.How crypto payment platform. Under the agreement, both companies will explore the collaboration and marketing on such products including KYN’s Koinfold Exchange, Koinfold Pay, NFTs, deployment of blockchain nodes, and a digital wallet under their Pay.How app. https://kyncap.com Pay.How is a super app which converges peer-to-peer payments, merchant solutions, real estate, home services, ticketing to events, ride sharing, and a crypto exchange into a streamlined and rewarding experience. KYN Capital and DogeLabs,...

Continue reading

GEMXX CORPORATION POSTS POSITIVE QUARTERLY RESULTS OF OPERATIONS

Las Vegas, NV, Nov. 04, 2021 (GLOBE NEWSWIRE) — GEMXX Corporation (OTC Pink: GEMZ) (“GEMXX”) ($GEMZ) (“the Company”), a leader in the Ammolite Gemstone Mine to Market Segment, posts positive quarterly revenues and highlighting significant achievements solidifying its strong foundation for growth in the coming year.    “We are very pleased with the performance of Company through this pandemic.” Stated Jay Maull, GEMXX Corporation, CEO. “We continue to build a solid base of reoccurring revenue by signing supply agreements and multi order deals. This is due to the team’s hard-work and determination and the company’s ability to offer the best quality Ammolite Gems and Jewelry in this sector.” Shares issued and outstanding remain the same at 97,466,757. The Quarter’s Account Receivables have increased to $458,172.00 compared to...

Continue reading

Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences’ Lead Drug Candidate

It states, “No evidence of data manipulation was found for Western blot data.” AUSTIN, Texas, Nov. 04, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) has been informed by the Journal of Neuroscience that there is no evidence of data manipulation in an article it published in July 2012 describing a new approach to treating Alzheimer’s disease1. The peer-reviewed article was co-authored by scientists and academic collaborators for Cassava Sciences and is foundational to simufilam, the Company’s lead drug candidate for the proposed treatment of Alzheimer’s disease. “I’ve never doubted the integrity of our people or science,” said Remi Barbier, President & CEO. “We remain focused on conducting a Phase 3 clinical program of simufilam in people with Alzheimer’s disease. It’s an important endeavor, notwithstanding...

Continue reading

Grace congratulates UNIPOL® PP Technology Licensee, Braskem, for first year of successful operation

COLUMBIA, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) — W. R. Grace & Co. (Grace), the leading independent supplier of polyolefin catalyst technology and polypropylene (PP) process technology, is pleased to announce that its UNIPOL® PP technology licensee, Braskem, has successfully completed one year of commercial production at its newest, world-class 450 KTA polypropylene production line in La Porte, Texas. Grace provided state-of-the-art PP design technology and innovations to meet Braskem’s need to manufacture a wide breadth of polypropylene products for its customers. The La Porte commercial production line has the capability to produce a full range of homopolymer, random copolymer, and impact copolymer products. In accordance with Grace and Braskem’s shared commitment to sustainability, the plant was also designed with...

Continue reading

Risk Strategies Acquires Hibbits Insurance, Inc., Expanding Nationwide Employee Benefits Footprint

Strengthening South Carolina local market presence BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Risk Strategies, a leading national specialty insurance brokerage and risk management firm, today announced it has acquired benefits general agent and retail property & casualty agency Hibbits Insurance, Inc. Terms of the deal were not announced. Founded in Orangeburg and headquartered in Mount Pleasant, South Carolina, Hibbits is a full-service insurance brokerage specializing in group and individual health, life, and disability insurance. It is the first South Carolina-based acquisition for Risk Strategies and the second benefits general agency the company has acquired, as it continues to grow and strengthen its specialty offerings. “Hibbits is a well-respected leader in South Carolina and has become a trusted partner for many employers...

Continue reading

New Chicken Soup for the Soul Streaming Service Launches

Beloved Publishing Megabrand ‘Chicken Soup for The Soul’ Brings Its Original Mission of “Changing Your World One Story at The Time” To Linear FAST Platforms Ahead of Full AVOD Launch COS COB, Conn., Nov. 04, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, announced today the launch of its new free ad-supported streaming service, Chicken Soup for the Soul, which is now available as a FAST channel on Plex, FreeCast, and Redbox, with LG Channels, Stirr, XUMO, and VIZIO’s free streaming service WatchFree joining in December. Additional platforms will roll out prior to the launch of a full Chicken Soup for the Soul AVOD offering, which will be available in coming weeks. The Chicken Soup for the Soul...

Continue reading

Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer 

ASHBURN, Va., Nov. 04, 2021 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has appointed Gordon Dunn as Quoin’s Chief Financial Officer, effective immediately. Mr. Dunn has over 30 years of finance experience. He has served as CFO of both private and publicly traded companies and has deep experience in investment banking and private equity as well. During the past five years he has served as Chief Financial Officer for several private companies, most recently with Qured, a UK-based healthcare provider, from 2020 to 2021. Mr. Dunn also served as CFO of Innocoll AG. from 2012-2016. Dr. Michael Myers, Chief Executive Officer of Quoin, commented, “Gordon Dunn has the right experience to serve as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.